Health Condition 1: - Health Condition 2: - Health Condition 3: - Health Condition 4: E789- Disorder of lipoprotein metabolism, unspecified
Conditions
Interventions
Intervention1: Interventional
Yavalauh churan
: In interventional,Yavalauh churan is given in the dose of 5gms BD with Madhu for 2 months.
Control Intervention1: Comparator agent
Tab Atorvastatin: I
Sponsors
SGT University
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients willing for trial is the foremost criteria. 2. Patients having one or more parameters of deranged lipid profile.
Exclusion criteria
Exclusion criteria: 1. Patients having serious ailments like Type 1 DM or poorly controlled Type 2 DM, MI, Cardiac failure, Renal insufficiency, Hypothyroidism, Glucocortico-steroids induced dyslipidemia. 2. Patients on statins/any other drug. 3. The patients more than 40 BMI will not be taken. 4. Pregnant females and lactating mothers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Symptomatically, patients will be evaluated as per the scoring pattern. 2.Changes in objective criteria i.e. lipid profile will be analysed and effectiveness of trial drug will be evaluated. 3.normalcy of lipid profile will be the main primary outcome.Timepoint: 1.Symptomatically, patients will be evaluated as per the scoring pattern. 2.Changes in objective criteria i.e. lipid profile will be done on baseline, after 2 months and then one month after completion of the therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that weight and hence, BMI of the patients will be reduced during and after the treatment.Timepoint: BMI will be reduced. | — |
Countries
India
Contacts
Public ContactDr Rekha Phull
SGT University, Gurugram
Outcome results
None listed